Gyre Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 1,619,176 | 1.89% |
Individual Insiders | 5,785,119 | 6.74% |
General Public | 14,412,090 | 16.8% |
Public Companies | 64,005,887 | 74.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
64,005,887 | US$826.3m | 0% | no data | |||
2,942,467 | US$38.0m | 0% | no data | |||
2,840,376 | US$36.7m | 0% | no data | |||
499,489 | US$6.4m | 0% | no data | |||
340,171 | US$4.4m | 46.9% | no data | |||
303,647 | US$3.9m | 16.9% | no data | |||
113,648 | US$1.5m | 392% | no data | |||
104,490 | US$1.3m | 8.76% | no data | |||
94,758 | US$1.2m | 190% | no data | |||
26,634 | US$343.8k | 0% | 0.08% | |||
18,799 | US$242.6k | 0% | no data | |||
18,039 | US$232.9k | 149% | no data | |||
12,507 | US$161.4k | -31.5% | no data | |||
10,424 | US$134.6k | 1.29% | no data | |||
9,472 | US$122.3k | 0% | no data | |||
9,288 | US$119.9k | 282% | no data | |||
7,481 | US$96.6k | 410% | no data | |||
5,076 | US$65.5k | 225% | no data | |||
4,941 | US$63.8k | -0.56% | no data | |||
3,861 | US$49.9k | 0% | no data | |||
3,742 | US$48.3k | 0% | no data | |||
3,730 | US$48.2k | -0.59% | no data | |||
3,643 | US$47.0k | 71.6% | no data | |||
3,103 | US$40.1k | 3.88% | no data | |||
3,029 | US$39.1k | 1.92% | no data |